The Latest Cardiac and Vascular News
Company to accelerate clinical testing and prepare for commercialization of its broad portfolio products Prairie Village, KS – April 29, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today the closing of an additional $12 million […]
CLICHY, France–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT). The company presented the first ever study demonstrating […]
FDA approval results in the only label of its kind for more than 3 million patients in the United States, significantly expanding AtriCure’s addressable market Superiority trial showed a 29% difference in effectiveness at 12 months and a 35% difference in effectiveness at 18 months for long-standing persistent Afib patients. Study […]
Proven Leader Will Take Revolutionary Heart Failure Therapy Company to Next Level SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter-based Ventricular Restoration (TCVR), today announced that Jim Dillon has been named President and CEO. In his role, Mr. […]
MORRISVILLE, N.C., April 28, 2021 /PRNewswire/ — A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately detect myocardial ischemia. The article demonstrated MyoStrain’s speed and sensitivity […]
Published Study Shows Combined Decrease in Heart Attacks and Strokes Among MDVIP Patients Relative to the General Population BOCA RATON, Fla., April 29, 2021 /PRNewswire/ — New research from MDVIP shows that its personalized and preventive approach to primary care helps reduce the incidence of cardiovascular events in at-risk patients. The study, […]
Cardiologists at Henry Ford Hospital Led the Development of Shock Treatment Protocol DETROIT, April 28, 2021 /PRNewswire/ — The results of a large, national heart attack study show that patients with a deadly complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at […]
LJUBLJANA, Slovenia, April 29, 2021 /PRNewswire/ — MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech […]
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first patients have been treated in the post-market surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm, open-label study that will follow patients treated with […]
Device further expands the range of blood vessels that can now be treated for ischemic stroke. NETANYA, Israel, April 29, 2021 /PRNewswire/ — Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, today announced the first successful clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, […]
